Molecular analysis of aberrant signal transduction of membrane receptors as a basis for diagnosis and treatment of malignant lymphomas

膜受体异常信号转导的分子分析作为恶性淋巴瘤诊断和治疗的基础

基本信息

  • 批准号:
    14370067
  • 负责人:
  • 金额:
    $ 8.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

(1)Hodgkin's lymphoma and anaplastic large cell lymphomas (ALCL) : We demonstrated that the constitutive activation of NF-kB results from "ligand-independent activation" of overexpressed CD30 on the Hodgkin/Reed-Sternberg (H-RS)cells, and that inhibition of CD30 signaling by transduction of a dominat negative decoy CD30 that lacks the cytoplasmic region induced apoptotic cell death of H-RS cells (Horie et al., Oncogene 21,2493,2002). We shoed that cytoplasmic aggregation of TRAF2 and TRAF5 proteins represents constant signaling of CD30 (Horie et al., Am J Pathol 160,1647,2002). We demonstrated that the AP-1 binding sequence located near the microsatellite counteracts the suppressive effects of the microsatellite on the CD30 promoter activity (Watanabe et al., Am J Pathol 163,633,2003). We showed that p80NPM-ALK inhibits ligand-independent signal transduction by overexpressed CD30 in ALCL cells though sequestration of TRAF proteins in the complex of NPM-ALK and wild type NPM (Horie et al., Cancer Cell 5,353,2004).(2)ATL :We demonstrated that GSK-3b-b-catenin-TCF/LEF pathway is a possible downstream target of the constitutively activated PKCbll in ATL cells.Expression profile analysis of ATL cells identified 67 genes as specifically overexpressed ones in ATL cells, 44 in activated T-cells of PBMC of HTLV-1 carriers, 24 in HTLV-1 infected cell lines.We revealed 5'-LTR specific CpG heavy methylation of HTLV-1 provirus in ATL cells and infected T-cells in peripheral blood of symptomatic carriers, which may be one base for latent infection of HTLV-1 (Koiwa et al., J Virol 76,9389,2002).
(1)Hodgkin's lymphoma and anaplastic large cell lymphomas (ALCL) : We demonstrated that the constitutive activation of NF-kB results from "ligand-independent activation" of overexpressed CD30 on the Hodgkin/Reed-Sternberg (H-RS)cells, and that inhibition of CD30 signaling by transduction of a dominat negative decoy CD30 that lacks the cytoplasmic region诱导H-RS细胞的凋亡细胞死亡(Horie等人,癌基因21,2493,2002)。我们说,TRAF2和TRAF5蛋白的细胞质聚集代表CD30的恒定信号传导(Horie等,Am J Pathol 160,1647,2002)。我们证明,位于微卫星附近的AP-1结合序列抵消了微卫星对CD30启动子活性的抑制作用(Watanabe等人,AM J Pathol 163,633,2003)。我们表明,p80NPM-Alk抑制了ALCL细胞中CD30过表达的CD30的非配体信号转导,但NPM-Alk-all-all型和野生型NPM中TRAF蛋白的固相抑制了(Horie等人,癌细胞5,353,2004)。 constitutively activated PKCbll in ATL cells.Expression profile analysis of ATL cells identified 67 genes as specifically overexpressed ones in ATL cells, 44 in activated T-cells of PBMC of HTLV-1 carriers, 24 in HTLV-1 infected cell lines.We revealed 5'-LTR specific CpG heavy methylation of HTLV-1 provirus in ATL cells and infected T-cells in peripheral blood有症状的载体,这可能是HTLV-1潜在感染的基础之一(Koiwa等,J Virol 76,9389,2002)。

项目成果

期刊论文数量(45)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma
  • DOI:
    10.1016/s1535-6108(04)00084-4
  • 发表时间:
    2004-04-01
  • 期刊:
  • 影响因子:
    50.3
  • 作者:
    Horie, R;Watanabe, M;Watanabe, T
  • 通讯作者:
    Watanabe, T
Watanabe M, Ogawa Y, Ito K, et al.: "AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells"American Journal of Pathology. 163. 633-641 (2003)
Watanabe M、Okawa Y、Ito K 等人:“AP-1 介导解除霍奇金细胞和里德-斯滕伯格细胞中 CD30 启动子微卫星的抑制活性”美国病理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horie R, Higashihara M, Watanabe T.: "Hodgkin's Lymphoma and CD30 signal transduction"International Journal of Hematology. 77. 37-47 (2003)
Horie R、Higashihara M、Watanabe T.:“霍奇金淋巴瘤和 CD30 信号转导”国际血液学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tobinai K, Watanabe T, Jaffe E.: ""HTLV-1-associated adult T-cell leukemia-lymphoma" in Non-Hodgkin Lymphomas"Edited by Mauch PM, Armitage JO, Harris NL, Dalla-Favera R, Coiffier B Lippincott Williams & Wilkins (in press). (2003)
Tobinai K、Watanabe T、Jaffe E.:“非霍奇金淋巴瘤中的“HTLV-1 相关成人 T 细胞白血病淋巴瘤””由 Mauch PM、Armitage JO、Harris NL、Dalla-Favera R、Coiffier B Lippincott 编辑
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells
  • DOI:
    10.1016/s0002-9440(10)61112-1
  • 发表时间:
    2002-05-01
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Horie, R;Watanabe, T;Watanabe, T
  • 通讯作者:
    Watanabe, T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WATANABE Toshiki其他文献

WATANABE Toshiki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WATANABE Toshiki', 18)}}的其他基金

HTLV-1 hijacks T-cell differentiation/function by deregulatingHelios gene expression
HTLV-1通过解除Helios基因表达调控来劫持T细胞分化/功能
  • 批准号:
    23659484
  • 财政年份:
    2011
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Oncogene addiction of ATL cells and abnormal Polycomb-miRNA-signal transduction
ATL细胞的癌基因成瘾和异常的Polycomb-miRNA信号转导
  • 批准号:
    23390250
  • 财政年份:
    2011
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pursuit of a new system for a high throughput screening of drugs to develop a new strategy of prevention and treatment of ATL
追求高通量药物筛选新系统,制定ATL防治新策略
  • 批准号:
    20390267
  • 财政年份:
    2008
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Abnormalities in TCR signal transduction in T cell non-Hodgkin's lymphoma as a basis for a new classification system.
T 细胞非霍奇金淋巴瘤中 TCR 信号转导异常作为新分类系统的基础。
  • 批准号:
    18390111
  • 财政年份:
    2006
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of zooxanthellate genes that are involved in symbiosis with a reef coral, and analyses of their function and expression
鉴定与珊瑚礁共生相关的虫黄藻基因,并分析其功能和表达
  • 批准号:
    16510157
  • 财政年份:
    2004
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploration of sub-seafloor methanehydrate using artificial current source ocean-bottom electromagnetic method and its reservoir estimation
人工电流源海底电磁法勘探海底甲烷水合物及其储层估算
  • 批准号:
    16360449
  • 财政年份:
    2004
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on abnormalities of membrane receptor signaling in malignant lymphoma cells as a basis of diagnosis and treatment
恶性淋巴瘤细胞膜受体信号异常作为诊断和治疗依据的研究
  • 批准号:
    16390103
  • 财政年份:
    2004
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular studies on the formation of calcified hard tissues in marine crustaceans
海洋甲壳动物钙化硬组织形成的分子研究
  • 批准号:
    08833004
  • 财政年份:
    1996
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of genes involved in the multistep leukemogenesis of ATL
参与 ATL 多步白血病发生的基因的表征
  • 批准号:
    08457273
  • 财政年份:
    1996
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies for developing a laboratory diagnostic system for cancers by means of PCR that is applicale to clinical samples such as urine and stool
研究开发适用于尿液和粪便等临床样本的 PCR 癌症实验室诊断系统
  • 批准号:
    05557059
  • 财政年份:
    1993
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似国自然基金

FOXM1/ISG15轴调控线粒体自噬维持ALK+ALCL干性导致化疗耐药的机制研究
  • 批准号:
    82300223
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
铝-硫电池用AlCl3/乙酰胺电解液改性研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    64 万元
  • 项目类别:
ALK阳性T细胞淋巴瘤中两个癌相关蛋白相互作用研究
  • 批准号:
    31100549
  • 批准年份:
    2011
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
四氢双环戊二烯选择性异构催化剂的研究
  • 批准号:
    21076031
  • 批准年份:
    2010
  • 资助金额:
    36.0 万元
  • 项目类别:
    面上项目
间变型大细胞淋巴瘤中ALK/PI3K/AKT/mTOR信号通路的活化与糖皮质激素耐药的关系及其临床意义
  • 批准号:
    30800494
  • 批准年份:
    2008
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance
ALCL 的未来:新疗法、起源、生物标志物和耐药机制
  • 批准号:
    EP/X042308/1
  • 财政年份:
    2023
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Research Grant
ALCL病態に関わる異常DNAメチル化の解明
阐明与 ALCL 病理相关的异常 DNA 甲基化
  • 批准号:
    22K07195
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of germline mutations on the development of breast-implant associated anaplastic large cell lymphoma (BIA-ALCL) in women with textured breast implants
种系突变对有纹理乳房植入物的女性发生乳房植入物相关间变性大细胞淋巴瘤 (BIA-ALCL) 的影响
  • 批准号:
    10685505
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
Impact of germline mutations on the development of breast-implant associated anaplastic large cell lymphoma (BIA-ALCL) in women with textured breast implants
种系突变对有纹理乳房植入物的女性发生乳房植入物相关间变性大细胞淋巴瘤 (BIA-ALCL) 的影响
  • 批准号:
    10512644
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
被膜拘縮を抑制するペプチドコーティング乳房インプラントの開発
开发抑制包膜挛缩的肽涂层乳房植入物
  • 批准号:
    22K09857
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了